E-LIB Suche - Ergebnisse für: Bezhanova, L. S.

1

The content of soluble forms of galectins -1, -3, -4, -7, -..:

Kushlinskii, Nikolay E. ; Kovaleva, Olga V. ; Basov, Arseniy G....
Almanac of Clinical Medicine. , 2024

2

Organ-preserving surgical treatment of a patient with synch..:

K. A. Turupaev ; A. V. Klimov ; O. A. Khalmurzaev...
https://oncourology.abvpress.ru/oncur/article/view/1688/1499. , 2024

Link: https://oncourology.abvp..

3

Metastasis suppressor kisspeptin (KISS1) in serum of patien..:

N. E. Kushlinskii ; O. V. Kovaleva ; E. S. Gershtein...
https://oncourology.abvpress.ru/oncur/article/view/1724/1492. , 2024

Link: https://oncourology.abvp..

4

Dynamical behaviour of phase transitions in liquid crystals..:

Bezhanova, L S ; Vasilyan, M S ; Atanesyan, A K
Journal of Physics: Conference Series. 2657 (2023) 1 - p. 012011 , 2023

Link: https://doi.org/10.1088/..

5

Prognostic significance of sPD-1/sPD-L1 in renal cancer dep..:

O. V. Kovaleva ; A. N. Gratchev ; E. I. Makarova...
https://oncourology.abvpress.ru/oncur/article/view/1556/1364. , 2022

Link: https://oncourology.abvp..

6

Prognostic significance of sPD-1/sPD-L1 in renal cancer dep..:

O. V. Kovaleva ; A. N. Gratchev ; E. I. Makarova...
https://oncourology.abvpress.ru/oncur/article/view/1556. , 2022

Link: https://doi.org/10.17650..

7

Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and..:

Kushlinskii, N. E. ; Gershtein, E. S. ; Alferov, A. A....
Bulletin of Experimental Biology and Medicine. 168 (2020) 5 - p. 673-676 , 2020

Link: https://doi.org/10.1007/..

8

Key VEGF signaling system components and matrix metalloprot..:

Kushlinskii N.E ; Gershtein E.S ; Kolpakov A.V...
https://almclinmed.ru/jour/article/view/1255/1199. , 2020

Link: https://almclinmed.ru/jo..

9

Clinical implication of kidney injury molecule (KIM-1) in b..:

E. S. Gershtein ; D. S. Naberezhnov ; A. A. Alferov...
https://oncourology.abvpress.ru/oncur/article/view/1375. , 2020

Link: https://doi.org/10.17650..

10

Key VEGF signaling system components and matrix metalloprot..:

N. E. Kushlinskii ; E. S. Gershtein ; A. V. Kolpakov...
https://www.almclinmed.ru/jour/article/view/1255. , 2020

Link: https://doi.org/10.18786..

11

Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patient..:

Kushlinskii, N. E. ; Gershtein, E. S. ; Naberezhnov, D. S....
Bulletin of Experimental Biology and Medicine. 167 (2019) 3 - p. 388-392 , 2019

Link: https://doi.org/10.1007/..

12

Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) i..:

Kushlinskii, N. E. ; Gershtein, E. S. ; Morozov, A. A....
Bulletin of Experimental Biology and Medicine. 166 (2019) 3 - p. 353-357 , 2019

Link: https://doi.org/10.1007/..

13

Soluble forms of the immune check-point receptor PD-1 and i..:

N. Kushlinskii E ; E. Gershtein S ; I. Goryatcheva O...
https://oncourology.abvpress.ru/oncur/article/view/874/822. , 2019

Link: https://oncourology.abvp..

14

Prognostic role of PBRM1 marker expression in clear-cell re..:

D. G. Zaridze ; N. N. Mazurenko ; S. D. Bezhanova...
https://oncourology.abvpress.ru/oncur/article/view/896. , 2019

Link: https://doi.org/10.17650..

15

Soluble forms of the immune check-point receptor PD-1 and i..:

N. E. Kushlinskii ; E. S. Gershtein ; I. O. Goryatcheva...
https://oncourology.abvpress.ru/oncur/article/view/874. , 2019

Link: https://doi.org/10.17650..